FDA panel recommends CRT-D for mildy symptomatic HF patients Cardiovascular Business 7 in a three-to-two vote that the overall clinical benefits of Medtronic's cardiac resynchronization therapy with implantable cardioverter-defibrillator (CRT-D) devices outweigh the risks in treating certain mildly symptomatic heart failure (HF) ... FDA Advisory Panel Recommends Expanded Indication for Medtronic Cardiac ... FDA Panel Recommends Expanding Medtronic Heart Device Use Medtronic Defibrillators Win FDA Panel Backing for Wider Use |
